Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 1519 Records) |
Query Trace: Colorectal Neoplasms and Kras[original query] |
---|
Genomic Landscape of Advanced Solid Tumors in Middle East and North Africa Using Circulating Tumor DNA (ctDNA) in Routine Clinical Practice. Oncology 2024 9 1-24. Shaheenah Dawood, Nippun Sandhir, Marwan Akasheh, Maroun El Khoury, Sonia Otsmane, Muath Alnassar, Omalkhair Abulkhair, Fadi Farhat, Steve Ols |
Associations of SEMA7A, SEMA4D, ADAMTS10, and ADAM8 with KRAS, NRAS, BRAF, PIK3CA, and AKT Gene Mutations, Microsatellite Instability Status, and Cytokine Expression in Colorectal Cancer Tissue. Current issues in molecular biology 2024 9 46 (9): 10218-10248. B?a?ej Ochman, Piotr Limanówka, Sylwia Mielcarska, Agnieszka Kula, Miriam Dawidowicz, Wiktor Wagner, Dorota Hudy, Monika Szrot, Jerzy Zbigniew Piecuch, Jerzy Piecuch, Zenon Czuba, El?bieta ?wi?tochows |
Molecular genetic analysis of colorectal carcinoma with an aggressive extraintestinal immunohistochemical phenotype. Scientific reports 2024 9 14 (1): 22241. Jan Hrudka, Markéta Kalinová, Hana Fišerová, Karolína Jelínková, Andrej Nikov, Petr Waldauf, Radoslav Mat |
The prognostic significance of growth pattern, tumor budding, poorly differentiated clusters, desmoplastic reaction pattern and tumor-stroma ratio in colorectal cancer and an evaluation of their relationship with KRAS, NRAS, BRAF mutations. Annals of diagnostic pathology 2024 9 73 152375. Duygu Unal Kocabey, I Ebru Cak |
Genomic profiling of colorectal cancer in large-scale Chinese patients: amplification and somatic mutations in ERBB2. Oncology research 2024 9 32 (9): 1429-1438. Yuzhi Liu, Evelyne Bischof, Zhiqin Chen, Jiahuan Zhou, Bei Zhang, Ding Zhang, Yong Gao, Ming Qu |
Molecular profiling of risk factors for relapse in Japanese patients with stage II colorectal cancer: a retrospective cohort study. International journal of clinical oncology 2024 9 . Shunsuke Kasai, Hiroyasu Kagawa, Keiichi Hatakeyama, Akio Shiomi, Shoichi Manabe, Yusuke Yamaoka, Yusuke Tanaka, Takahiro Igaki, Takeshi Nagashima, Keiichi Ohshima, Kenichi Urakami, Yasuto Akiyama, Yusuke Kinugasa, Ken Yamaguc |
Combined KRAS and TP53 mutation in patients with colorectal cancer enhance chemoresistance to promote postoperative recurrence and metastasis. BMC cancer 2024 9 24 (1): 1155. YiMeng Tang, Yao F |
PLK1 and its role in the evolving landscape of KRAS-mutated colorectal cancer. Journal of gastrointestinal oncology 2024 9 15 (4): 1987-1992. Harry Harvey, Eric Xueyu Ch |
Molecular, Socioeconomic, and Clinical Factors Affecting Racial and Ethnic Disparities in Colorectal Cancer Survival. JAMA oncology 2024 9 . Mahmoud Yousef, Abdelrahman Yousef, Saikat Chowdhury, Mohammad M Fanaeian, Mark Knafl, Jennifer Peterson, Mohammad Zeineddine, Kristin Alfaro, Fadl Zeineddine, Drew Goldstein, Nicholas Hornstein, Arvind Dasari, Ryan Huey, Benny Johnson, Victoria Higbie, Alisha Bent, Bryan Kee, Michael Lee, Maria Pia Morelli, Van Karlyle Morris, Daniel Halperin, Michael J Overman, Christine Parseghian, Eduardo Vilar, Robert Wolff, Kanwal P Raghav, Michael G White, Abhineet Uppal, Ryan Sun, Wenyi Wang, Scott Kopetz, Jason Willis, John Paul Sh |
Mutation patterns in colorectal cancer and their relationship with prognosis. Heliyon 2024 9 10 (17): e36550. Zhaoran Su, Maria El Hage, Michael Linnebach |
Prevalence of KRAS amplification in patients with metastatic cancer: Real-world next-generation sequencing analysis. Pathology, research and practice 2024 8 261 155473. Dae-Ho Choi, Hye-Lim Jang, Sung Hee Lim, Seung Tae Kim, Jung Yong Hong, Se Hoon Park, Joon Oh Park, Deok Geun Kim, Kyoung-Mee Kim, Jeeyun L |
Evolution of Colorectal Cancer Trends and Treatment Outcomes: A Comprehensive Retrospective Analysis (2019-2023) in West Kazakhstan. Asian Pacific journal of cancer prevention : APJCP 2024 8 25 (8): 2773-2785. Nauryzbay Imanbayev, Yerbolat Iztleuov, Arip Koishybaev, Nurgul Kereyeva, Anar Tulyaeva, Dinara Zholmukhamedova, Azamat Zharylgap |
PIK3CA Mutated Colorectal Cancers Without KRAS, NRAS and BRAF Mutations Possess Common and Potentially Targetable Mutations in Epigenetic Modifiers and DNA Damage Response Genes. Cancer genomics & proteomics 2024 8 21 (5): 533-548. Ioannis A Voutsadak |
Kinetic Profiling of RAS Mutations With Circulating Tumor DNA in the Canadian Cancer Trials Group CO.26 Trial Suggests the Loss of RAS Mutations in Neo-RAS-Wildtype Metastatic Colorectal Cancer Is Transient. JCO precision oncology 2024 8 8 e2400031. Florence T H Wu, James T Topham, Chris J O'Callaghan, Harriet Feilotter, Hagen F Kennecke, Leylah Drusbosky, Daniel J Renouf, Derek J Jonker, Dongsheng Tu, Eric X Chen, Jonathan M Lor |
Molecular characteristics of patients with colorectal signet-ring cell carcinoma with different ABO blood groups. Heliyon 2024 8 10 (13): e34220. Wan-Ning Zhang, Wei-Jie Liang, Ying Zhang, Ming-Jian Liang, Ming-Juan Zhang, Qi Chen, Zhou-Pei Mo, Mei-Yi Wu, Xue-Zi Weng, Rui Han, Yong-Neng Liang, Miao-La Ke, Wen-Qian L |
Association of genetic ancestry with molecular tumor profiles in colorectal cancer. Genome medicine 2024 8 16 (1): 99. Brooke Rhead, David M Hein, Yannick Pouliot, Justin Guinney, Francisco M De La Vega, Nina N Sanfo |
The KRAS G12D mutation increases the risk of unresectable recurrence of resectable colorectal liver-only metastasis. Surgery today 2024 7 . Kai Chen, Yukiyasu Okamura, Keiichi Hatakeyama, Akio Shiomi, Hiroyasu Kagawa, Hitoshi Hino, Shoichi Manabe, Yusuke Yamaoka, Teiichi Sugiura, Takashi Sugino, Akifumi Notsu, Takeshi Nagashima, Keiichi Ohshima, Kenichi Urakami, Yasuto Akiyama, Ken Yamaguc |
Targeted panel sequencing of pharmacogenes and oncodrivers in colorectal cancer patients reveals genes with prognostic significance. Human genomics 2024 7 18 (1): 83. Lucie Heczko, Václav Liška, Ond?ej Vy?ítal, Ond?ej Fiala, Simona Š?sová, Viktor Hlavá?, Pavel Sou? |
KRAS Exon 2 Mutations in Patients with Sporadic Colorectal Cancer: Prevalence Variations in Mexican and Latin American Populations. Cancers 2024 7 16 (13): . José Luis Venegas-Rodríguez, Jesús Arturo Hernández-Sandoval, Melva Gutiérrez-Angulo, José Miguel Moreno-Ortiz, Anahí González-Mercado, Jorge Peregrina-Sandoval, Helen Haydee Fernanda Ramírez-Plascencia, Beatriz Armida Flores-López, Carlos Rogelio Alvizo-Rodríguez, Jesús Alonso Valenzuela-Pérez, Sergio Cervantes-Ortiz, María de la Luz Ayala-Madrig |
Clinical features associated with NeoRAS wild-type metastatic colorectal cancer A SCRUM-Japan GOZILA substudy. Nature communications 2024 7 15 (1): 5885. Hiroki Osumi, Eiji Shinozaki, Yoshiaki Nakamura, Taito Esaki, Hisateru Yasui, Hiroya Taniguchi, Hironaga Satake, Yu Sunakawa, Yoshito Komatsu, Yoshinori Kagawa, Tadamichi Denda, Manabu Shiozawa, Taroh Satoh, Tomohiro Nishina, Masahiro Goto, Naoki Takahashi, Takeshi Kato, Hideaki Bando, Kensei Yamaguchi, Takayuki Yoshi |
Genetic Testing of Japanese Patients with Serrated Polyposis Syndrome: A Multicentric Study. Journal of the anus, rectum and colon 2024 10 8 (4): 348-355. Akinari Takao, Tatsuro Yamaguchi, Hidetaka Eguchi, Yasushi Okazaki, Hideki Ishikawa, Kiwamu Akagi, Hideyuki Ishi |
Associations of KRAS Mutations and Clinical Characteristics of Colorectal Cancer Patients in Indonesia. Asian Pacific journal of cancer prevention : APJCP 2024 10 25 (10): 3457-3461. Reno Rudiman, Ahmad N Alfarisy, Kiki Lukman, Prapanca Nugraha, Yoopie Setiawan, Yunia Sribudia |
Multigene Panel Next-Generation Sequencing Techniques in the Management of Patients with Metastatic Colorectal Carcinoma: The Way Forward for Personalized Treatment? A Single-Center Experience. International journal of molecular sciences 2024 10 25 (20): . Laura Matteucci, Francesco Giulio Sullo, Chiara Gallio, Luca Esposito, Margherita Muratore, Ilario Giovanni Rapposelli, Daniele Calistri, Elisabetta Petracci, Claudia Rengucci, Laura Capelli, Elisa Chiadini, Paola Ulivi, Alessandro Passardi, Alessandro Bitto |
CDX2-Suppressed Colorectal Cancers Possess Potentially Targetable Alterations in Receptor Tyrosine Kinases and Other Colorectal-Cancer-Associated Pathways. Diseases (Basel, Switzerland) 2024 10 12 (10): . Ioannis A Voutsadak |
KRAS Gene Mutation Associated with Grade of Tumor Budding and Peripheral Immunoinflammatory Indices in Patients with Colorectal Cancer. International journal of general medicine 2024 10 17 4769-4780. Liu Liang, Xuemin Guo, Wei Ye, Yuxiang L |
Clinical impact of TP53 functional mutations in patients with metastatic colorectal cancer treated with bevacizumab and chemotherapy. The oncologist 2024 10 . Annamaria Ruzzo, Francesco Graziano, Silvia Palladino, Nicholas W Fischer, Vincenzo Catalano, Paolo Giordani, David Malkin, Tiziana Tamburrano, Alberto Patriti, Filippo Petrelli, Donatella Sarti, Rita Chia |
Unveiling the role of KRAS in Chinese colorectal cancer patients: a positive influence on tumor mutational burden. Translational cancer research 2024 10 13 (9): 4752-4762. Xuebin Wan, Xiaoni Zhang, Mingyan Xu, Zhi Zheng, Yujun Zhou, Zhiyong Zho |
TAS-102 (trifluridine/tipiracil) plus bevacizumab versus TAS-102 alone as salvage treatment options for metastatic colorectal cancer in routine clinical practice. Frontiers in oncology 2024 10 14 1450732. Ji Eun Shin, Sung Hee Lim, Jeeyun Lee, Ho Yeong Lim, Young Suk Park, Seung Tae K |
Prediction of metachronous advanced colorectal neoplasia by KRAS mutation in polyps. United European gastroenterology journal 2024 10 . Alejandro Martínez-Roca, Joaquín Cubiella, Anabel García-Heredia, David Guill-Berbegal, Sandra Baile-Maxía, Carolina Mangas-Sanjuán, Noelia Sala-Miquel, Lucía Madero-Velazquez, Cristina Alenda, Pedro Zapater, Clara González-Núñez, Agueda Iglesias-Gómez, Laura Codesido-Prado, Astrid Díez-Martín, Michal F Kaminski, Rune Erichsen, Hans-Olov Adami, Monika Ferlitsch, María Pellisé, Øyvind Holme, Evelien Dekker, Michael Bretthauer, Rodrigo Jover, |
Colorectal Cancer Brain Metastasis With Concomitant KRAS and BRAF Mutations: A Case Report. Cureus 2024 10 16 (9): e68975. Alexandra Vesa, Octavian Maghiar, Ottó Molnar, Ovidiu Pop, Adrian Maghi |
- Page last reviewed:Feb 1, 2024
- Content source: